RETRACTED: exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma

C Ding, X Yi, X Wu, X Bu, D Wang, Z Wu, G Zhang… - 2020 - Elsevier
Following the publication of the above article, the authors further investigated the effects of
co-delivery of miR-132 (a key miRNA in the above article) and temozolomide with …

Profiles of immune‐related genes and immune cell infiltration in the tumor microenvironment of diffuse lower‐grade gliomas

X Deng, D Lin, X Zhang, X Shen, Z Yang… - Journal of cellular …, 2020 - Wiley Online Library
The tumor microenvironment is highly correlated with tumor occurrence, progress, and
prognosis. We aimed to investigate the immune‐related gene (IRG) expression and immune …

Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas via Large-Scale Analysis

X Huang, F Zhang, D He, X Ji, J Gao, W Liu… - Frontiers in …, 2021 - frontiersin.org
Background Glioma is one of the highly fatal primary tumors in the central nervous system.
As a major component of tumor microenvironment (TME), immune cell has been proved to …

Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas?

R Rudà, M Touat, R Soffietti - Current Opinion in Neurology, 2020 - journals.lww.com
Is chemotherapy alone an option as initial treatment for low... : Current Opinion in Neurology Is
chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas? : Current …

Age and surgical outcome of low‐grade glioma in Sweden

A Corell, L Carstam, A Smits… - Acta neurologica …, 2018 - Wiley Online Library
Background Low‐grade gliomas (LGG) are slow‐growing primary brain tumors that typically
affect young adults. Advanced age is widely recognized as a poor prognostic factor in LGG …

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort

P Dao Trong, M Gluszak, D Reuss… - Journal of Neuro …, 2023 - Springer
Purpose Lower-grade glioma (LGG) is rare among patients above the age of 60 (“elderly”).
Previous studies reported poor outcome, likely due to the inclusion of isocitrate …

The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma

RS Youland, CR Kreofsky, DA Schomas… - Journal of neuro …, 2017 - Springer
Despite recent randomized, prospective evidence supporting use of RT and chemotherapy
(CRT) for high-risk low-grade gliomas (LGG), many patients have historically received RT …

Risk prediction and treatment assessment in glioma patients using SEER database: a prospective observational study

XR Li, Y Shao, ZM Wang, JQ Zhu - BMJ open, 2023 - bmjopen.bmj.com
Objectives To use a nomogram to predict the risk of mortality and estimate the impact of
current treatment on the prognosis of glioma patients. Methods A total of 3798 cases were …

Isocitrate dehydrogenase mutations in low-grade gliomas correlate with prolonged overall survival in older patients

PS Jones, KT Carroll, M Koch, JAT DiCesare… - …, 2019 - journals.lww.com
BACKGROUND Older age has been associated with worse outcomes in low-grade gliomas
(LGGs). Given their rarity in the older population, determining optimal treatment plans and …

Low grade gliomas guide-lines elaborated by the tumor section of Spanish Society of Neurosurgery

ST Solís, JG Sánchez, II Lozano, GP Ahicart… - Neurocirugía (English …, 2023 - Elsevier
Adult low-grade gliomas (Low Grade Gliomas, LGG) are tumors that originate from the glial
cells of the brain and whose management involves great controversy, starting from the …